Loading...

1,830 posters, 67 videos, 75 audios, 29 topics, 22 sessions, 4,727 authors, 1,697 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

RCOG World Congress 2023

June 12 - 14, 2023 | London, UK

RCOG World Congress 2023 banner

EP.1231

Overcoming the gynaecological backlog – how useful can robotic surgery be?

Part of Topic

Hot Topics (Emerging research/issues) in Gynaecology

Overcoming the gynaecological backlog – how useful can robotic surgery be?

Maleeha Mansura, Myint Winb, Lisa Huntc, Tunde Dadac, Deepa Balachandran Nairc

aST3,  bTrust Registrar, cConsultant Obstetrician & Gynaecologist - Buckinghamshire NHS Trust

Background & Objectives

•The NHS is in crisis with wait-times for gynaecological surgery being longest on record, 40% of patients having referral to treatment times over  18 weeks, the highest of all specialities (RCOG 2022).
•Added to this is the increasing complexity of cases. Robotic surgery offers inherent advantages of early discharge and reduced bed pressure.
•We review current evidence on robotic surgery with special relevance to gynaecology and explore how this can help with managing the current backlog.
 

General

•Since the da Vinci Robotic Surgical System was approved

by the Food and Drug Administration for use in

gynaecological  surgery in 2005, robotic surgery has

gained much popularity, with multiple models available

and the fourth generation of robots now in use.

•Robotic surgery has several major operative advantages

over conventional laparoscopy - 3D visualisation,

improved ergonomics, extended articulation and 

tremor filtering - all of which translate to reduced blood

loss, complication rates, and length of hospital stay.

•Improved clinical outcomes are of particular significance

in obese and morbidly obese patients.

•Disadvantages of robotic surgery include increased set-

up and operating times, the need to accommodate and

maintain large sophisticated equipment, requirement

for additional training and the cost of a robot.

•In a systematic cost review of gynaecological surgery

over 23 studies, the mean  charge for hysterectomy was

€684 to €25,616 for open, €858 to €25,578 for

laparoscopic and €936 to €33,920 for robotic surgery. 

 

Technical aspects and outcomes

•Robotic surgery is equipment-intensive and requires an appropriate surgical suite to

accommodate the patient cart, the vision system, and the surgeon's console.

•Inappropriate patient positioning is associated with inadequate exposure of the operative

field as well as detrimental complications that may lead to long-term side effects. In our

experience a steep 30 degree trendelenburg position is required to facilitate surgery.

•One of the challenges highlighted was intraoperative communication. One study

demonstrated a significant association between poor intraoperative team communication

and worse surgical outcomes in robotic gynaecologic surgery, the most common reasons

reported for poor communication in the operating room were noise level (78%) and

console-to-bedside communication problems (64%).

•Surgery performed at lower-pressure pneumoperitoneum (<= 10 mmHg) is associated with

lower postoperative pain scores, shorter length of stay, and improved intraoperative

respiratory parameters without increased duration of surgery or blood loss6.

•In most of the series, operating time is longer with a robot, but complication rates are

decreased, especially in obese patients with conversion to laparotomy less as compared to

standard laparoscopy.

•The average operative time for robotic assisted laparoscopic hysterectomy reported was

110-140min.

• The EBL was < 100 ml in all studies.
•All studies were in accordance with reduced post-operative hospital stay, reporting an

average of 2 days for total hysterectomy and 1 day for adnexal surgery . 

 

Complications

•In a study of 296

patients evaluating

the risk of pulmonary

Complications, a low

rate of 2% was found.

Similarly, in a  study of

1032 obese patients, a 

a similar rate of 3% pulmonary complication was reported,

with an overall  complication rate of 14%.

• A systematic review of bowel injuries sustained in robotic

gynaecology surgery reported an incidence of 0.62%, with

87% being recognized intraoperatively and the majority

(58%) managed via a minimally invasive approach with no

deaths as a result of bowel injury.

•In a systematic review of 1488 patients undergoing robotic-

assisted sacrocolpopexy, the incidence of post-site hernias

was found to be 0.4%. (conventional laparoscopy <1%).

Training

•A prospective study on a 3-half-day

experiencing and training session,

found no major peri-, or post-

operative complications, with

reducing operating suturing time

with progressive sessions.

•A 7-year evaluation of robotic

sacrocolpopexy found mean

operative time reduced  from 5.3 to

3.6 hours, reaching this plateau after

60 cases.

•Robotic surgery has the advantage of

the potential use of virtual reality

simulation to test for procedural

competency.

•A review of current surgical training

amongst European Oncology

Trainees found only 23% of trainees

had exposure to robotic surgery,

with 62.4% expressing that  it

should be a formal component of 

training.5

 

Conclusion

•Robotic surgery has always been looked at as an expensive modality. Heavy resource limitations, increasing benign

gynaecology  waiting times and case-complexity demand an active search for alternative ways of offering effective

and timely patient care.

•This literature review supports increasing use of robotic surgery to tackle the gynaecological surgical backlog .
•The ability to operate at reduced pressure along with reduced complication rate and blood loss and better intraoperative

recognition  of complications contribute to reduced hospital stay and increased scope for day surgery, all of which have the

potential to  reduce bed-pressure with significant cost saving.

•Evidence shows distinct advantages  of robotic surgery in high complexity patients, in particular obese and morbidly obese

Patients,  which has become a problem since the Covid-19 pandemic (The King’s Fund)

•Reduced pulmonary complications will translate to reduced ITU admissions and overall hospital stay.
•The waiting list initiatives and all day lists have been proposed to clear the backlog – reduced surgical fatigue due to 

inherent technical advantages of the robot, facilitates throughput of large case numbers promoting pathway efficiency.

•Covid-19 has also highlighted deficiencies in surgical training and robotic surgery provides an opportunity to train the  future

surgeon. The review supports an appetite for exposure to robotic surgery which may well be accepted standard in the future.

•Despite the initial investment, we believe that robotic surgery does provide long-term return on investment with cost savings

from reduced length of hospital stay and will help in  tackling the surgical backlog.

RCOG World Congress 2023 » banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.